40 results
8-K
EX-99.1
AORT
Artivion Inc
1 Apr 20
Results of Operations and Financial Condition
4:30pm
to COVID-19 Pandemic
ATLANTA, GA – (April 1, 2020) – CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic … Mackin, Chairman, President, and Chief Executive Officer. “While the full short term impact on us of the pandemic is not known, we believe we are well
8-K
EX-99.2
AORT
Artivion Inc
31 Jul 20
Results of Operations and Financial Condition
9:59am
in the face of, and in some cases, a resurgence of the COVID-19 pandemic, we are optimistic that given the nature of our products we can deliver solid … . We will also continue to diligently manage our expenses while strategically investing for growth, now and when the pandemic subsides
8-K
EX-99.1
AORT
Artivion Inc
31 Jul 20
Results of Operations and Financial Condition
9:59am
business is weathering the pandemic well, as we believe the majority of products in our portfolio are used in procedures that cannot be postponed … -GAAP constant currency basis, both compared to the second quarter of 2019. Decreases in all product lines reflect the impact of the COVID-19 pandemic
8-K
EX-99.1
AORT
Artivion Inc
4 Nov 20
Results of Operations and Financial Condition
4:10pm
business is weathering the pandemic well and we continue to progress on our strategic initiatives,” commented Pat Mackin, Chairman, President, and Chief … . Revenue performance across all product lines reflected the impact of the COVID-19 pandemic on the number of procedures using our products.
Net loss
8-K
EX-99.1
ptj1 1poz
11 Feb 21
Results of Operations and Financial Condition
4:33pm
8-K
EX-99.1
eq2htgyscq5 62upsqj
30 Apr 20
Entry into a Material Definitive Agreement
4:24pm
8-K
ha1vyqte
30 Apr 20
Entry into a Material Definitive Agreement
4:24pm